Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.

Antiviral therapy - 1 Jan 2015

Abbas Zaigham, Yakoob Javed, Umer Muhammad A, Abbas Minaam, Hamid Saeed

Abstract excerpt

BACKGROUND: Specific single nucleotide polymorphisms (SNPs) near the interferon lambda-3 (IFNλ3) gene (formerly interleukin 28B) influence the response to treatment with interferon in hepatitis C patients. We aimed to investigate such an influence in hepatitis D patients. METHODS: The study population consisted of hepatitis D patients who were previously treated with pegylated interferon for one year and who were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to gamma-Glutamyltransferase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis Delta Virus

Share to Interferon-alpha

Share to Interferons

Share to Interleukins

Share to Liver Cirrhosis

Share to Polyethylene Glycols

Source

Identifiers

PMID: 25668821
DOI: 10.3851/IMP2943

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D.PMID 25668821Read ↗

Interferon Lambda-3 rs12979860 Variants and Response to Pegylated Interferon in Chronic Hepatitis-C Genotype-3.Semantic proximity Read ↗

Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection.Semantic proximity Read ↗

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?Semantic proximity Read ↗

Association between IFN-λ 3 Gene Polymorphisms and Outcome of Treatment with Direct Acting Antivirals in Chronic HCV-Infected Egyptian Patients.Semantic proximity Read ↗

Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.Semantic proximity Read ↗

IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.Semantic proximity Read ↗

The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C.Semantic proximity Read ↗

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.Semantic proximity Read ↗

Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.Semantic proximity Read ↗

The Impact of interferon lambda 3 Polymorphism on Hepato-Cellular Carcinoma Progression in Hepatitis C Virus Patients: Treatment-Naïve and Experienced.Semantic proximity Read ↗

IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.Semantic proximity Read ↗

Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.